We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Applovin Corporation | NASDAQ:APP | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.61 | 6.66% | 73.82 | 73.25 | 75.00 | 74.59 | 69.97 | 70.09 | 5,381,253 | 01:00:00 |
From Apr 2023 to Apr 2024
By Ben Glickman
AppLovin reported a better-than-expected profit in the second quarter as the company's sales rose. The software company posted net income of $80.36 million, or 22 cents a share, while analysts polled by FactSet expected earnings of 8 cents a share. Shares climbed 24% to $36.48 in after-hours trading.
Walt Disney said it would significantly raise prices for its Disney+ and Hulu streaming services as it looks to make its direct-to-consumer business profitable. The streaming segment's loss narrowed in the second quarter, posting a loss of $512 million compared with $1.06 billion a year earlier. Disney shares rose 2.7% to $89.87 in after-hours trading.
Galera Therapeutics said the Food and Drug Administration told the company that results for one of its drug candidates weren't enough to warrant approval. The company said it would reduce its workforce by 70% in order to extend its cash runway following the FDA's decision. Shares fell 82% to 41 cents in after-hours trading.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
August 09, 2023 19:55 ET (23:55 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Applovin Chart |
1 Month Applovin Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
